euro adhoc: LION Bioscience AG
Annual & Special Corporate Meetings
/ LION bioscience Announces Extraordinary Shareholder Meeting to
Reorganize the Company
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
14.02.2005
Cambridge, MA, USA, Heidelberg, Germany, February 14, 2005 - LION bioscience today announced there will be an extraordinary shareholder meeting on March 24, 2005. The reason for the meeting is the management's intention to strategically reorganize the company, which requires changes and enlargements in the company's articles. The invitation for the extraordinary shareholder meeting will be published on February 14, 2005 in the German Federal Gazette.
Following resolutions will be resubmitted among others to the shareholders of LION bioscience: strategic reorganization, changes and enlargements in the articles of the company such as the company's objectives and the authorization for LION bioscience to repurchase own shares.
The goal of the restructuring is to orient the company towards profitability and shareholder value. This can be achieved by transforming the company into a holding structure and by separating the operating businesses from headquarter functions. With these measures it is expected, that LION will be profitable from on the next fiscal year 2005/2006 starting April 1, 2005.
end of announcement euro adhoc 14.02.2005 13:00:00
Further inquiry note:
Günter Dielmann
Vice President Investor Relations
+49 (0) 6221-4038 249
guenter.dielmann@lionbioscience.com
Julia Fritz
Public Relations Officer
+49 (0) 6221-4038 158
julia.fritz@lionbioscience.com
Branche: Pharmaceuticals
ISIN: DE0005043509
WKN: 504350
Index: Nemax 50, Prime Standard, TecDAX
Börsen: Frankfurter Wertpapierbörse / regulated dealing
Berliner Wertpapierbörse / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Niedersächsische Börse zu Hannover / free trade
Bayerische Börse / free trade
Bremer Wertpapierbörse (BWB) / free trade